Arch Dental Clinic Dentist Medicare: Not Enrolled in Medicare Practice Location: 200 Westgate Dr, Suite 2, Brockton, MA 02301 Phone: 508-587-5333 |
Siri C Steinle Dmd Pc Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 1058 North Main St, Brockton, MA 02301 Phone: 508-583-3171 Fax: 508-583-3180 |
Elite Dental Group Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 76 South St, Brockton, MA 02301 Phone: 508-583-1772 Fax: 508-560-5616 |
Dr. Gabriella Babu Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 839 Pleasant St, Brockton, MA 02301 Phone: 508-583-3530 Fax: 508-583-7642 |
Brockton Smiles Youth Dentistry, Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 70 Westgate Dr, Brockton, MA 02301 Phone: 508-588-8090 Fax: 508-588-8010 |
Cortland Dental Dentist - Endodontics Medicare: Not Enrolled in Medicare Practice Location: 715 Crescent St, Suite 9, Brockton, MA 02302 Phone: 678-904-5665 |
Michael L. Shapiro, Dmd,p.c. Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 838 Pleasant St, Brockton, MA 02301 Phone: 508-586-6002 |
Belmont Family Dental Center Of Brockton Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 185 Belmont St, Brockton, MA 02301 Phone: 508-586-2668 |
Vagenas Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 5 Torrey St, Brockton, MA 02301 Phone: 508-586-4276 Fax: 508-513-1403 |
News Archive
Illumina, Inc. today announced the launch of a Cancer Analysis Service from the Illumina Genome Network (IGN) that leverages the high accuracy of Illumina technologies to provide cancer researchers with easily interpretable tumor/normal sequencing data to quickly move their research forward.
Acute kidney injury (AKI) is a frequent complication in patients in intensive care. A new laboratory test called urine neutrophil gelatinase associated lipocalin (NGAL) helps predict if patients will develop acute kidney injury, reports an upcoming study in the Journal of the American Society of Nephrology (JASN).
Halozyme Therapeutics, Inc. today announced that it has closed the previously announced $150 million royalty-backed debt transaction with investment funds managed by Pharmakon Advisors and Athyrium Capital Management. The debt is secured by future royalties of ENHANZE products, received only from Halozyme's collaborations with Roche and Baxalta.
Implantable Provider Group is pleased to announce a significant agreement with Blue Cross and Blue Shield of Florida, Inc. to be its designated implantable device management vendor for its extensive provider network. IPG will handle device coordination, billing, replacement, tracking, and other services for BCBSF's statewide ambulatory surgery center (ASC) network.
› Verified 5 days ago